Moderna
MRNA
#1321
Rank
ยฃ10.93 B
Marketcap
ยฃ28.41
Share price
0.90%
Change (1 day)
-64.58%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -ยฃ7.37

According to Moderna 's latest financial reports the company's current EPS (TTM) is -ยฃ7.47. In 2022 the company made an earnings per share (EPS) of ยฃ17.26 a decrease over its 2021 EPS that were of ยฃ24.74.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ7.37-142.72%
2022ยฃ17.26-30.25%
2021ยฃ24.74-1660.82%
2020-ยฃ1.5925.16%
2019-ยฃ1.2737.04%
2018-ยฃ0.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.38-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.49-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.48-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.36-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.06-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-ยฃ1.39-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.51-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA